Last reviewed · How we verify
BBT-401-1S, Multiple doses
At a glance
| Generic name | BBT-401-1S, Multiple doses |
| Sponsor | Bridge Biotherapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.